Position
Quantbot Technologies LP in Supernus Pharmaceuticals, Inc.
Back to the book · All holders of SUPN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $8.08K$49.70 → $51.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.06K | $201.9K | — | — | — | 0.0% |
| Q1 2026 | 4.45K | $229.9K | $51.69 | $8.08K | $20K | 0.0% |